• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, July 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Examining the one-two punch of malaria drugs

Bioengineer by Bioengineer
May 5, 2021
in Chemistry
Reading Time: 2 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Why the combination medicines both help and hurt each other

IMAGE

Credit: University of Houston

When a mosquito begins to nibble on you, it is not merely feeding on your blood, it is also injecting its saliva into your skin. If that saliva happens to be full of parasites carrying malaria or other diseases from its last victim, then most likely you will become infected, too.

The first-line treatment for malaria, caused by the P. Falciparum parasite, is artemisinin-based combination therapy, which provides a one-two punch. The drug artemisinin (derived from the Asian Artemisia annua or sweet wormwood) is combined with a quinoline-based compound. Artemisinin weakens the parasite by oxidizing it; the quinoline drug kills it.

“But the two drugs do not always cooperate, they can also be antagonistic. Our purpose is to study the interactions between artemisinin and the drugs with which they are combined to fight malaria,” said Peter Vekilov, Moores Professor of Chemical and Biomolecular Engineering at the University of Houston. Vekilov received $1.2 million from the National Institute of Health, in partnership with Johns Hopkins University, to study the interactions of the drugs. Working with Vekilov is Jeff Rimer, Abraham E. Dukler Professor of Chemical and Biomolecular Engineering at UH.

As their name indicates, parasites know how to survive and adapt. When they begin to eat away at hemoglobin, hematin is produced. The toxic hematin itself could kill the parasite, but the parasite makes quick work of the hematin.

“The parasite knows how to deal with hematin, by sequestering it as innocuous crystals called hemozoin which are no longer toxic,” said Vekilov. “There is a crucial gap in the understanding of interactions between drug pairs relating to how they inhibit hemozoin formation.”

Many anti-malarial drugs work by inhibiting crystallization, which leaves the hematin soluble to kill the parasites. In previous work, Vekilov and Rimer proved artemisinin can also kill parasites by blocking crystallization.

Still, as a high-level organism, the parasite has adapted quickly and developed a pump, which pumps the drugs out in a process Vekilov likens to warfare.

“When you want to defend yourself against bullets, you use armor, but if you want to protect yourself against grenades, you throw them back,” he said. “The parasite uses the second strategy.”

Malaria kills more than 400,000 people around the world every year, mostly young children. Although it was eliminated from the United States 70 years ago, it still infects 2,000 Americans each year. According to the Centers for Disease Control and Prevention, malaria cases in the United States rose to 2,161 in 2017, the highest number in 45 years.

Artemisinin was discovered in 1971 by a Chinese scientist who won the Nobel Prize in 2015 for discovering its antimalarial properties.

“Our long-range goal is to develop a platform which will allow us to produce new drugs before the parasites develop resistance to the old ones, because that is inevitable,” said Vekilov.

###

Media Contact
Laurie Fickman
lafickman@uh.edu

Original Source

https://uh.edu/news-events/stories/2021/may-2021/05052021-vekilov-malaria-drugs-combination-antagonist.php

Tags: Biomedical/Environmental/Chemical EngineeringChemistry/Physics/Materials SciencesDeveloping CountriesDisease in the Developing WorldInfectious/Emerging DiseasesInternal MedicineMedicine/HealthneurobiologySocioeconomics
Share12Tweet8Share2ShareShareShare2

Related Posts

Architecture of VBayesMM

Unraveling Gut Bacteria Mysteries Through AI

July 4, 2025
Visulaization of ATLAS collision

Can the Large Hadron Collider Prove String Theory Right?

July 3, 2025

Breakthrough in Gene Therapy: Synthetic DNA Nanoparticles Pave the Way

July 3, 2025

Real-Time Electrochemical Microfluidic Monitoring of Additive Levels in Acidic Copper Plating Solutions for Metal Interconnections

July 3, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    56 shares
    Share 22 Tweet 14
  • New Organic Photoredox Catalysis System Boosts Efficiency, Drawing Inspiration from Photosynthesis

    54 shares
    Share 22 Tweet 14
  • Enhancing Broiler Growth: Mannanase Boosts Performance with Reduced Soy and Energy

    73 shares
    Share 29 Tweet 18
  • IIT Researchers Unveil Flying Humanoid Robot: A Breakthrough in Robotics

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Additive Manufacturing of Monolithic Gyroidal Solid Oxide Cells

Machine Learning Uncovers Sorghum’s Complex Mold Resistance

Pathology Multiplexing Revolutionizes Disease Mapping

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.